(Q40622113)

22 September 2017

title

Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells (English)

1 reference

22 September 2017

0 references

6

Jia Liu

1 reference

22 September 2017

Qian Wang

1

1 reference

22 September 2017

Hong Li

2

1 reference

22 September 2017

Xiao-Wei Wang

3

1 reference

22 September 2017

Da-chang Wu

4

1 reference

22 September 2017

Xiao-Yan Chen

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

13 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583387

full work available at URL

26 March 2024

https://api.elsevier.com/content/article/PII:S0304394003008942?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

https://api.elsevier.com/content/article/PII:S0304394003008942?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

26 March 2024

1 reference

22 September 2017

volume

351

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

83-86

1 reference

Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Unusual delayed complication of central venous access.

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Establishment and characterization of four human medulloblastoma-derived cell lines

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

IL-6 Stimulates Growth and Inhibits Constitutive, Protein Synthesis-Independent Apoptosis of Murine B-Cell Hybridoma 7TD1

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Focus on central nervous system neoplasia

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Medulloblastoma: clinical and biologic aspects

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Medulloblastoma: a problem of developmental biology

26 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts

26 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2003.07.002

26 March 2024

Identifiers

1 reference

22 September 2017

1 reference